Trademark: 79165656
Word
GENOSCREEN
Status
Registered
Status Code
739
Status Date
Tuesday, December 13, 2022
Serial Number
79165656
Registration Number
4980234
Registration Date
Tuesday, June 21, 2016
Mark Type
4000
Filing Date
Friday, January 30, 2015
Published for Opposition
Tuesday, April 5, 2016

Trademark Owner History
GENOSCREEN - Original Registrant

Classifications
9 [ Measuring instruments and devices, namely, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; computer programs for research and analysis in the fields of science, biology, biotechnology, biochemistry, genomics, proteomics, transcriptomics, genetics, life sciences, cloning, human health, diagnostics and in the processing of biological data; software for scientific analysis of genetic sequences and biological platelets for use in the scientific research industry and in the field of genetics; ] computer programs and software incorporating algorithms designed for research and analysis in the fields of science, biology, biotechnology, biochemistry, genomics, proteomics, transcriptomics, genetics, life sciences, cloning, human health, diagnostics and in the processing of biological data [; computer programs designed for scientific analysis of genetic sequences and biological platelets for use in scientific research; computer programs designed to identify DNA, detect diseases, test and develop drugs; analysis apparatus, not for medical use, namely, scales, sequencers, analyzers and captors; apparatus for testing air, water, food, namely, scales, sequencers, analyzers and captors; chemistry apparatus and instruments, namely, sequencers, chemistry analyzers and captors ;diagnostic apparatus, not for medical use, namely, sequencers, analyzers and captors; electronic quantity indicators for measuring blood and other bodily fluids; measuring instruments, namely, scales, analyzers and captors; DNA chips ]
5 [ Pharmaceutical products, namely, pharmaceutical products for treatment of cancer, infectious diseases, tuberculosis and for Alzheimer detection and treatment; veterinary products, namely, veterinary products for treatment of cancer, infectious diseases, tuberculosis and Alzheimer detection and treatment; chemical preparations for medical use in the treatment of cancer, infectious diseases, tuberculosis and Alzheimer detection and treatment; ] diagnostic preparations for medical and veterinary use but not for immunodiagnostic and HIV tests; diagnostic products for medical use, namely, reagents and assays [; chemical reagents for medical or veterinary purposes but not for immunodiagnostic and HIV tests; preparations of microorganisms for medical and veterinary use ]
1 [ Chemicals, other than for use in immunodiagnostics and HIV tests, for use in industry, science, as well as in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; ] chemical preparations for making diagnoses in laboratories other than for medical or veterinary purposes and other than immunodiagnostics and HIV tests; [ chemical reagents, other than those used for medical, veterinary, immunodiagnostic and HIV tests; biological, biochemical, and chemical reagents for non-medical purposes for the improvement of molecules, other than those used for HIV and immunodiagnostics tests; ] biological preparations other than for medical or veterinary use for use for identifying and testing various complex microbiological samples, including human micro biota, soils, water, air and food; chemical products for creating genetic marker libraries in order to genotype a complex micro biota population and for making diagnoses in laboratories other than for medical or veterinary purposes for use in the fields of biology, biotechnology, biochemistry, genomics, proteomics, transcriptomics, genetics and life sciences, other than those used for HIV and immunodiagnostics tests; diagnostic kits comprised of bio chemicals, namely, cells, antibodies, antigens, and gene banks containing bio technologically formed genes, as well as mutation and molecular variant banks containing bio technologically formed genes for in vitro scientific research use and for diagnostics not for medical or veterinary purposes
42 Evaluations, analyses, scientific research and technological testing services of flora, metagenomes, microorganisms, micro biota or transcriptomics in the field of [ pharmacy, chemistry, ] biotechnology, [ biochemistry, ] genomics, bacteriology, transcriptomics, genetics, and life sciences; [ biomedical research, and biological, medical and veterinary product development; providing laboratory research services in the field of gene expression and protein profiling, namely, cancer infectious diseases, tuberculosis, Alzheimer biology; ] genotyping services for research and analysis purposes for genotyping based on biological markers; design and development of programming databases in the field of [ pharmaceuticals, ] biotechnology, biology, [ biochemistry, ] genomics, transcriptomics, genetics, and life sciences; clinical laboratory testing services, namely, gene sequencing-based testing services with a view to research relating to genome sequencing of plants and animals, micro-organisms, sequencing of DNA or RNA and epigenetic sequencing; development and updating of computer programs designed for scientific analysis of genetic sequences, genetic sequencing of the genes of individuals and cohorts; [ electronic data storage and computer programming services for publishing data in a computer science environment designed for bioinformatics; bioinformatics computer engineering; laboratory research services in the field of large-scale DNA sequencing; development and updating of data management systems; database design and development applications in general of biological data processing; scientific development and technical validation of micro-satellite and mini-satellite markers; scientific services in the field of genomics for use in laboratories working on all kinds genomes, including human, animal and micro-organisms, namely, scientific development and validation of micro-satellite and mini-satellite markers; ] scientific services in the field of genomics for use in laboratories working on all kinds genomes, including human, animal and micro-organisms, namely, identification, typing, tracing, analysis and creation of a bank and a database, treatments resistance prediction, whole genome sequencing and complete flora; scientific research, mutation detection and identification of microorganisms; [ scientific research, namely, mutation detection and identification of microorganisms; genotyping services for research or analyses purposes; ] development and testing of computer databases, software, algorithms and computing methods for generating and analyzing biological, genetic and epidemiological data [; scientific research and development services in the fields of diagnostic methods, antibody technology, and gene expression systems; rental of software and computer databases; scientific research and development services; medical laboratory services ]

Trademark Events
Jun 8, 2023
Teas Change Of Correspondence Received
Jun 8, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 8, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 13, 2022
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Dec 13, 2022
Registered - Sec. 71 Accepted & Sec. 15 Ack.
Dec 9, 2022
Teas Response To Office Action-Post Reg Received
Nov 30, 2022
Teas Change Of Correspondence Received
Nov 30, 2022
Teas Change Of Domestic Representatives Address
Nov 30, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 30, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 30, 2022
Teas Change Of Correspondence Received
Nov 30, 2022
Teas Change Of Domestic Representatives Address
Nov 30, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 30, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 9, 2022
Office Action Issued Pou1
Jun 8, 2022
Case Assigned To Post Registration Paralegal
Jun 2, 2022
Teas Section 71 & 15 Received
Jun 21, 2021
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 9, 2020
New Representative At Ib Received
Oct 16, 2016
Final Decision Transaction Processed By Ib
Sep 22, 2016
Final Disposition Notice Sent To Ib
Sep 22, 2016
Final Disposition Processed
Sep 21, 2016
Final Disposition Notice Created, To Be Sent To Ib
Jul 12, 2016
Teas Change Of Correspondence Received
Jun 21, 2016
Registered-Principal Register
Apr 5, 2016
Official Gazette Publication Confirmation E-Mailed
Apr 5, 2016
Published For Opposition
Apr 1, 2016
Notification Processed By Ib
Mar 16, 2016
Notification Of Possible Opposition Sent To Ib
Mar 16, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 16, 2016
Notification Of Notice Of Publication E-Mailed
Mar 2, 2016
Law Office Publication Review Completed
Feb 22, 2016
Approved For Pub - Principal Register
Dec 30, 2015
Teas/Email Correspondence Entered
Dec 30, 2015
Correspondence Received In Law Office
Dec 30, 2015
Assigned To Lie
Dec 10, 2015
Teas Response To Office Action Received
Jun 27, 2015
Refusal Processed By Ib
Jun 10, 2015
Non-Final Action Mailed - Refusal Sent To Ib
Jun 10, 2015
Refusal Processed By Mpu
Jun 8, 2015
Non-Final Action (Ib Refusal) Prepared For Review
Jun 7, 2015
Non-Final Action Written
Jun 5, 2015
Application Filing Receipt Mailed
Jun 1, 2015
Assigned To Examiner
Jun 1, 2015
New Application Office Supplied Data Entered
May 30, 2015
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24